Long-Term Assets: The sum of all assets classified as non-current.
IN8bio, Inc. (INAB) had Long-Term Assets of $8.37M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-30.44M |
|
-- |
|
-- |
|
$30.67M |
|
$-30.67M |
|
$0.23M |
|
$-30.44M |
|
$-30.44M |
|
$-30.44M |
|
$-30.44M |
|
$-30.44M |
|
$-30.44M |
|
$-30.67M |
|
$-28.01M |
|
1.78M |
|
1.78M |
|
$-17.12 |
|
$-17.12 |
|
| Balance Sheet Financials | |
$12.58M |
|
$2.86M |
|
|
Long-Term Assets |
$8.37M |
$20.94M |
|
$3.08M |
|
$0.29M |
|
$3.38M |
|
$6.47M |
|
$14.48M |
|
$14.48M |
|
$14.48M |
|
2.41M |
|
| Cash Flow Statement Financials | |
$-24.15M |
|
$-0.19M |
|
$14.18M |
|
$21.54M |
|
$11.39M |
|
$-10.15M |
|
$5.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.08 |
|
-- |
|
-- |
|
0.02 |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-210.23% |
|
-210.23% |
|
-145.33% |
|
-206.03% |
|
$6.00 |
|
$-13.65 |
|
$-13.54 |
|